How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.

With Sidewinder, Ares graduated from a scanner that followed a script to an adversary that thinks. Where Dagger marched every target through the same fixed sequence of phases on a single fine-tuned ...

On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...

It's an upgrade worth making, but it comes down to your privacy concerns.

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

LinkDaddy has expanded Cloud Authority Backlinks, a multi-cloud SEO system that delivers DoFollow backlinks, machine-readable authority signals, and AI-ready content architecture for businesses and ...

On Wednesday, OpenAI took its biggest step yet towards full technological independence with the unveiling of a new AI chip, dubbed Jalapeño, that it developed in collaboration with U.S. chipmaker ...

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...